CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Cavapharma

Cavapharma is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tethys Bioscience

Tethys Bioscience is a personalized predictive medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes.

Exogenesis Corporation

Exogenesis Corporation is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CredSimple

CredSimple is a new kind of Credentials Verification Organization (CVO) built on sophisticated technology and a partnership mindset. Payers choose us above competitors because these core values allow us to make a meaningful difference to their operations and, therefore, business.

Parma Care Ctr

Parma Care Ctr is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.